Anticoagulant activity of heparin: Assay of bovine, human and porcine preparations by amidolytic and clotting methods

Thrombosis Research

Volumn 11, Issue 2, 1977, Pages 107-117

  Teien, Arne N ^a,b   Abildgaard, Ulrich ^a,b   Höök, Magnus ^a,b   Lindahl, Ulf ^a,b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b Royal Veterinary College   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; HEPARIN CALCIUM; HEPARIN NYCO; UNCLASSIFIED DRUG;

BLOOD CLOTTING; DRUG COMPARISON; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; METHODOLOGY; THEORETICAL STUDY;

ANIMAL; ANTITHROMBINS; AZO COMPOUNDS; BLOOD COAGULATION; CALCIUM; CATTLE; FACTOR X; HEPARIN; HUMAN; IN VITRO; SWINE; THROMBIN;

EID: 0017742052     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(77)90029-9     Document Type: Article

References (21)

1. Chemistry and pharmacology of heparin
2. Variation in commercial heparin and its relation to the problem of heparin standardization for clinical use
3. The platelet aggregating effect of eight commercial heparins
4. A collaborative study of heparins from different sources
5. Anticoagulant action of heparin
6. The anticoagulant effect of heparan sulfate and dermatan sulfate
7. The coagulation of blood
8. Anticoagulant activity of heparin: Separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin
9. Purification of antithrombin III by affinity chromatography
10. Standard for human thrombin
11. The specific assay of Prower-Stuart factor and factor VII
12. Synthetic chromogenic substrates for determination of trypsin, thrombin and thrombin-like enzymes
13. Determination of factor Xa activity by means of chromogenic substrates based on the primary structure of prothrombin
14. Heparin assay in plasma: A comparison of five clotting methods
15. The activation of antihemophilic factor (factor VIII) by activated christmas factor (factor IX)
16. Antithrombin III, antifactor Xa and heparin
17. Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor